With nearly half million votes cast, researchers involved in ground-breaking innovation receive $100,000 to advance commercialization efforts
(L-R) Thomas Thornton and Michael Dowling present a 100,000 check to researchers Daniel Grande, PhD, Lee Smith, MD , Todd Goldstein and Kevin Tracey, MD
MANHASSET, NY — Northwell Health (formerly North Shore-LIJ Health System) today announced 3D bioprinting as the winner of its four-week-long medical innovation contest where public voting decided which of three medical innovations developed by researchers and physicians would receive $100,000 in additional research support.
Michael J. Dowling, president and chief executive officer at Northwell Health, today presented a $100,000 check to 3D bioprinting researchers Daniel Grande, PhD, Todd Goldstein of Northwell Health’s Feinstein Institute for Medical Research, and Lee Smith, MD, chief of pediatric otolaryngology at Cohen Children’s Medical Center to continue their research and help make this ground-breaking innovation a reality.
3D bioprinting combines two emerging fields — 3D printing and tissue engineering — to design and produce “bioprinted” implants that use a patient’s own living cells. “3D bioprinting’s potential is almost limitless and has the potential to replace many different parts of the human body,” said Mr. Dowling. “Researchers envision a future with 3-D printers in every emergency room, where doctors are able to print emergency implants of organs and bones on demand and revolutionize the way medicine is practiced.”
Northwell’s 3D printing team is led by Mr. Goldstein, an orthopedic research assistant who is working under Dr. Grande, an associate investigator at the Feinstein Institute and associate professor of molecular medicine and orthopedic surgery at Hofstra Northwell School of Medicine, while completing his PhD in molecular medicine at Hofstra Northwell. They began their 3D printing work several years ago by conducting research with bio-printed 3-D animal organs and bones. Other clinicians throughout Northwell Health, including cardiologists, otolaryngologists, thoracic surgeons and dentists, heard about Mr. Goldstein’s 3-D printing abilities and asked to work with him. As the demand increased, they discussed the benefits of creating a centralized 3-D printing lab.
Bolstered by the $100,000 investment and other support from Northwell Ventures to help commercialize their work, the 3D printing researchers will focus their efforts on providing end-to-end solutions for 3D printing in health care. On the researchers’ behalf, Northwell will consolidate all clinical 3D printing requirements throughout the health system, and establishes 3D printing services accessible to Northwell’s clinical service lines. “As one of the nation’s most innovate health systems, we believe there’s strong clinical demand for 3D printing and we’re working with our clinical partners and researchers to use these technologies to enhance patient care,” said Thomas Thornton, senior vice president and executive director of Northwell Ventures, which evaluates, develops and finances new spin-off companies based on ideas that originate with the health system’s physicians, researchers and other employees.
Patient ID Shield, Blood Loss Manager Also Show Promise
Of the total of 487,761 votes cast during the Northwell Innovation Contest over the past month, the 3D bioprinter received about 50 percent of total vote – 245,272. The other two medical innovations in the contest included:
- The Patient Identification Shield, a modern, non-transferable, easily removable, temporary stamp that serves as an alternative to the ubiquitous but antiquated hospital wristband. Efforts are being led by Peter D. Costantino, MD, senior vice president and executive director of head and neck services at Northwell Health, and chair of otolaryngology at Lenox Hill Hospital and at Hofstra Northwell.
- The Blood Loss Manager, a device that staunches blood loss in the operating room, in trauma situations and for military personnel on the battlefield. Research efforts are being led by Christopher J. Czura, PhD, vice president of scientific affairs at the Feinstein Institute.
The Patient Identification Shield was a close runner-up during the contest with about 45 percent of the vote (221,703). “Both the Patient Identification Shield and the Blood Loss Manager also show remarkable promise, and we will look for future opportunities to pursue additional research and future investment,” said Mr. Thornton.
To learn more about these three innovations go to www.northwell.edu/looknorth